Amniotic fluid embolism. A re-evaluation.
D000293:Adolescent; D000328:Adult; D000614:Aminocaproates / Q000627:therapeutic use; D001344:Autopsy; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004619:Embolism, Amniotic Fluid / Q000188:drug therapy / Q000209:etiology / Q000401:mortality / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D005260:Female; D005340:Fibrinogen / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D006931:Hyperbaric Oxygenation; D007263:Infusions, Parenteral; D007743:Labor, Obstetric; D008428:Maternal Mortality; D010276:Parasympatholytics / Q000627:therapeutic use; D011247:Pregnancy; D014662:Vasoconstrictor Agents / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use; D014680:Veins / Q000601:surgery
D000614:Aminocaproates; D004071:Digitalis Glycosides; D010276:Parasympatholytics; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D005340:Fibrinogen; D006854:Hydrocortisone